Please wait a minute...
浙江大学学报（医学版）
浙江大学学报（医学版）  2015, Vol. 44 Issue (5): 553-558    DOI: 10.3785/j.issn.1008-9292.2015.09.13
原著     
苏拉明对脓毒症小鼠肺组织和循环炎症反应的抑制作用
韩亮1,2, 侯金超1, 方向明1
1. 浙江大学医学院附属第一医院麻醉科, 浙江杭州 310003;
2. 浙江省人民医院麻醉科, 浙江杭州 310014
Inhibitory effect of suramin on inflammatory response in pulmonary tissue and peripheral blood in LPS-induced septic mice
HAN Liang1,2, HOU Jin-chao1, FANG Xiang-ming1
1. Department of Anesthesiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;
2. Department of Anesthesiology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China
全文: PDF(1148 KB)  
摘要: 

目的:观察苏拉明对脓毒症小鼠肺组织和循环炎症反应的抑制作用,并初步探讨其相关分子生物学机制。方法:①体内实验:将24只雄性C57BL/6小鼠按数字表法分为苏拉明组和生理盐水组,苏拉明组给予静脉注射5 mg/kg苏拉明预处理,生理盐水对照组给予等体积0.9%氯化钠溶液,30 min后采用静脉注射5 mg/kg脂多糖(LPS)建立脓毒症小鼠模型,检测不同时间点肺组织和外周血TNF-α和IL-6水平。②体外实验:苏拉明或生理盐水预处理人单核细胞系THP-1细胞30 min后,用100 ng/mL LPS刺激建立脓毒症细胞模型,于不同时间点收集THP-1细胞,提取RNA,定量PCR检测TNF-α和IL-6表达水平,并分离细胞浆和细胞核蛋白,蛋白质印迹法检测核因子κB(NF-κB)活性。结果:LPS干预后小鼠肺和外周血TNF-α和IL-6水平增加,提示成功建立脓毒症小鼠模型。与生理盐水组比较,苏拉明干预脓毒症小鼠模型作用24 h时小鼠肺组织及外周血TNF-α和IL-6的水平降低(均P<0.01);而苏拉明作用72 h时各组小鼠肺组织及外周血TNF-α和IL-6的水平差异无统计学意义(均P>0.05)。体外实验结果显示:苏拉明预处理减少LPS刺激THP-1细胞后TNF-α和IL-6的表达水平(均P<0.01),苏拉明预处理还减少LPS刺激30 min、60 min和90 min后THP-1细胞NF-κB的活化水平(均P<0.01)。结论:苏拉明可减轻小鼠全身及肺组织炎症反应,在对脓毒症肺损伤模型中具有保护作用,其炎症反应的调控可能与抑制脓毒症单核细胞的过度活化有关。
关键词 ： 苏拉明/药理学,  肺/损伤,  脓毒症/药物疗法,  肿瘤坏死因子-&alpha,  白细胞介素-6,  NF-&kappa,  B,  疾病模型,  动物    
Abstract：

Objective:To investigate the effect of suramin on inflammatory response in pulmonary tissue and peripheral blood in septic mice.Methods:Twenty-four male C57BL/6 mice were randomly divided into two groups, and suramin(5 mg/kg) or normal saline was intravenously injected 30 min before LPS(5 mg/kg)infusion, respectively. The contents of TNF-α and IL-6 in pulmonary tissue and peripheral blood were detected by ELISA. Suramin or saline-pretreated human mononuclear THP-1 cells were treated with 100 ng/mL LPS in vitro. The expression of TNF-α and IL-6 mRNA and the activity of NF-κB were analyzed by quantitative PCR and Western blotting at different time points after LPS treatment, respectively. Results:Compared with the saline group, the TNF-α and IL-6 levels in pulmonary tissue and peripheral blood were significantly reduced in suramin group at 24 h after LPS treatment(all P<0.01); while there was no significant difference at 72 h between two groups(all P>0.05). The expression of TNF-α, IL-6 mRNA and the activity of NF-κB was decreased in suramin group at different time points after LPS treatment. Conclusion:Suramin can protect LPS-induced acute lung injury through down-regulation of systemic and pulmonary pro-inflammatory factors, which may be associated with the inhibition of NF-κB activity.
Key words： Suramin/pharmacology    Lung/injuries    Sepsis/drug therapy    Tumor necrosis factor-alpha    Interleukin-6    NF-kappa B    Disease models, animal
收稿日期: 2015-03-23
CLC:  R515  
基金资助:

国家自然科学基金(81201495)
通讯作者: 方向明(1966-),女,博士,教授,主任医师,博士生导师,主要从事脓毒症发病机制及防治研究;E-mail:xiangming_fang@163.com;http://orcid.org/0000-0002-3471-5798     E-mail: xiangming_fang@163.com
作者简介: 韩亮(1979-),男,硕士研究生,主治医师,主要从事临床麻醉工作;E-mail:hzhanliang@sina.com;http://orcid.org/0000-0002-4691-2158
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　
韩亮
侯金超
方向明

引用本文:

韩亮, 侯金超, 方向明. 苏拉明对脓毒症小鼠肺组织和循环炎症反应的抑制作用[J]. 浙江大学学报（医学版）, 2015, 44(5): 553-558.
HAN Liang, HOU Jin-chao, FANG Xiang-ming. Inhibitory effect of suramin on inflammatory response in pulmonary tissue and peripheral blood in LPS-induced septic mice. Journal of ZheJiang University(Medical Science), 2015, 44(5): 553-558.

链接本文:

http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2015.09.13      或      http://www.zjujournals.com/xueshu/med/CN/Y2015/V44/I5/553

[1] SADOWITZ B, ROY S, GATTO L A, et al. Lung injury induced by sepsis:lessons learned from large animal models and future directones for treatment[J].Expert Rev Anti Infect Ther, 2011,9(12):1169-1178.
[2] DUSHIANTHAN A, GROCOTT M P, POSTLE A D, et a1. Acute respiratory distress syndrome and acute lung injury[J]. Postgrad Med J, 2011,87(1031):612-622.
[3] SMITH P D, SHIMAMURA M, MUSGROVE L C, et al. Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses[J]. J Immunol, 2014,193(11):5604-5612.
[4] JENKE A, WILK S, POLLER W, et al. Adiponectin protects against toll-like receptor 4-mediated cardiac inflammation and injury[J]. Cardiovasc Res, 2013,99(3):422-431.
[5] MANTOVANI A, SICA A, SOZZANI S, et al. The chemokine system in diverse forms of macrophage activation and polarization[J]. Trends Immunol, 2004,25(12):677-686.
[6] ZEMANS R L, COLGAN S P, DOWNEY G P. Transepithelial migration of neutrophils:mechanisms and implications for acute lung injury[J]. Am J Respir Cell Mol Biol, 2009,40(5):519-535.
[7] MEDURI G U, ANNANE D, CHROUSOS G P, et al. Activation and regulation of systemic inflammation in ards:rationale for prolonged glucocorticoid therapy[J]. Chest, 2009,136(6):1631-1643.
[8] SAPRU A, FLORI H, QUASNEY M W, et al. Pathobiology of acute respiratory distress syndrome[J]. Pediatr Crit Care Med, 2015,16(5 Suppl 1):S6-22.
[9] SAHU D, SAROHA A, ROY S, et a1. Suramin ameliorates collagen induced arthritis[J]. Int Immunopharmacol, 2012,12(1):288-293.
[10] LIU N, HE S, TOLBERT E, et al. Suramin alleviates glomerular injury and inflammation in the remnant kidney[J]. PLoS One, 2012,7(4):e36194.
[11] LIU N, TOLBERT E, PONNUSAMY M, et a1. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy[J]. J Pharmacol Exp Ther, 2011,338(3):758-766.
[12] ZHUANG S, LU B, DAUBERT R A, et a1. Suramin promotes recovery from renal ischemia/reperfusion injury in mice[J]. Kidney Int, 2009,75(3):304-311.
[13] LIU N, ZHUANG S. Tissue protective and anti-fibrotic actions of suramin:new uses of an old drug[J]. Curr Clin Pharmacol, 2011,6(2):137-142.
[14] EICHHORST S T, KRUEGER A, MUERKOSTER S, et al. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice[J]. Nat Med, 2004,10(6):602-609.
[15] SKIRECKI T, KAWIAK J, MACHAJ E, et al. Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice model[J]. Stem Cell Res Ther, 2015,6:142.
[16] BURAS J A, HOLZMANN B,SITKOVSKY M. Animal models of sepsis:setting the stage[J].Nat Rev Drug Discov,2005,4(10):854-865.
[17] DIAMANT G, DIKSTEIN R. Transcriptional control by NF-κB:elongation in focus[J]. Biochim Biophys Acta, 2013,1829(9):937-945.
[18] NAPETSCHNIG J, WU H. Molecular basis of NF-κB signaling[J]. Annu Rev Biophys, 2013,42:443-468.
[19] BAKER R G, HAYDEN M S, GHOSH S. NF-κB, inflammation, and metabolic disease[J]. Cell Metab, 2011,13(1):11-22.
[1] 张力三,陈冠峰,陈洁芳,何旭东,胡兴越. 组胺改善癫痫所致记忆形成障碍的实验研究[J]. 浙江大学学报（医学版）, 2017, 46(1): 1-6.
[2] 侯甲福,武蕾蕾,才玉婷,高长久,安锦丹,于忠诚. 锦花清热胶囊抗内毒素作用实验研究[J]. 浙江大学学报（医学版）, 2017, 46(1): 74-79.
[3] 汪锡婷,唐藕凤,叶夷露,郑鸣之,胡珏,陈忠,钟恺. 藏红花素对小鼠电点燃癫痫的影响[J]. 浙江大学学报（医学版）, 2017, 46(1): 7-14.
[4] 马婷婷,王毅,陈晓倩,赵筱萍. 液相色谱-质谱联用导向的黄葵胶囊肾保护活性物质研究[J]. 浙江大学学报（医学版）, 2017, 46(1): 66-73.
[5] 高思倩,沈咏梅,耿福能,李艳华,高建青. 糖尿病溃疡动物模型的建立及相关治疗研究进展[J]. 浙江大学学报（医学版）, 2017, 46(1): 97-105.
[6] 高思倩,沈咏梅,耿福能,李艳华,高建青. 颞叶癫痫与海马成体神经再生[J]. 浙江大学学报（医学版）, 2017, 46(1): 97-105.
[7] 李统宇 等. 杜氏肌营养不良疾病模型及基因治疗研究进展[J]. 浙江大学学报（医学版）, 2016, 45(6): 648-654.
[8] 方清清 等. 低频脉冲电磁场促进成骨细胞分化的基因调节和非基因调节探究[J]. 浙江大学学报（医学版）, 2016, 45(6): 568-574.
[9] 屈涛 等. 丹参素对去势大鼠骨质量的影响[J]. 浙江大学学报（医学版）, 2016, 45(6): 587-591.
[10] 高玉海 等. 淫羊藿总黄酮胶囊对生长期大鼠骨密度和骨形态计量学的影响[J]. 浙江大学学报（医学版）, 2016, 45(6): 581-586.
[11] 洪梦琪 等. 腹膜透析液通过上调葡萄糖转运体促进腹膜纤维化[J]. 浙江大学学报（医学版）, 2016, 45(6): 598-606.
[12] 林先刚 等. 姜黄素对慢性阻塞性肺疾病大鼠肺动脉平滑肌细胞的作用及其机制研究[J]. 浙江大学学报（医学版）, 2016, 45(5): 469-476.
[13] 刘军 等. 机体炎症因子和氧化应激标志物介导姜黄素抑制骨性关节炎的作用机制[J]. 浙江大学学报（医学版）, 2016, 45(5): 461-468.
[14] 白石 等. 雷公藤甲素缓解局灶性脑组织缺血再灌注损伤诱发的炎症及其相关凋亡的研究[J]. 浙江大学学报（医学版）, 2016, 45(5): 493-500.
[15] 吴志华 等. 异基因造血干细胞移植受者T细胞受体β链CDR3谱型表达与巨细胞病毒激活[J]. 浙江大学学报（医学版）, 2016, 45(5): 515-521.